https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.00418/full
Frontiers | In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02...
Romidepsin (RMD) is a well-characterized histone deacetylase inhibitor approved for the treatment of cutaneous T-cell lymphoma. In vitro and in vivo studies ...